speb/financial-data huggingface dataset:
CRNT income_statement (annual, 2022-12-31) — Other Operating Expenses: 4220000.00
CRNT balance_sheet (annual, 2022-12-31) — Other Payable: 2013000.00
CRNT balance_sheet (annual, 2022-12-31) — Other Properties: 17962000.00
CRNT balance_sheet (annual, 2022-12-31) — Other Receivables: 9256000.00
CRNT balance_sheet (annual, 2022-12-31) — Payables: 69397000.00
CRNT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 81820000.00
CRNT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 405000.00
CRNT income_statement (annual, 2022-12-31) — Pretax Income: -17243000.00
CRNT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 410000.00
CRNT balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRNT cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CRNT cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1957000.00
CRNT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -10464000.00
CRNT balance_sheet (annual, 2022-12-31) — Raw Materials: 35111000.00
CRNT balance_sheet (annual, 2022-12-31) — Receivables: 109290000.00
CRNT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 202110000.00
CRNT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 11040000.00
CRNT income_statement (annual, 2022-12-31) — Research And Development: 29690000.00
CRNT income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CRNT balance_sheet (annual, 2022-12-31) — Retained Earnings: -281408000.00
CRNT cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CRNT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 35795000.00
CRNT income_statement (annual, 2022-12-31) — Selling General And Administration: 70090000.00
CRNT balance_sheet (annual, 2022-12-31) — Share Issued: 87834902.00
CRNT income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CRNT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3560000.00
CRNT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 119783000.00
CRNT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 111575000.00
CRNT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -419100.00
CRNT income_statement (annual, 2022-12-31) — Tax Provision: 2446000.00
CRNT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.30
CRNT balance_sheet (annual, 2022-12-31) — Total Assets: 289318000.00
CRNT balance_sheet (annual, 2022-12-31) — Total Capitalization: 119783000.00
CRNT balance_sheet (annual, 2022-12-31) — Total Debt: 54432000.00
CRNT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 119783000.00
CRNT income_statement (annual, 2022-12-31) — Total Expenses: 306110000.00
CRNT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 169535000.00
CRNT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 78571000.00
CRNT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 36699000.00
CRNT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -10937000.00
CRNT income_statement (annual, 2022-12-31) — Total Unusual Items: -1397000.00
CRNT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1397000.00
CRNT balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 2653000.00
CRNT balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (annual, 2022-12-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (annual, 2022-12-31) — Work In Process: 143000.00
CRNT balance_sheet (annual, 2022-12-31) — Working Capital: 77911000.00
CRNT income_statement (annual, 2023-12-31) — +Operating Expense: 96644000.00
CRNT income_statement (annual, 2023-12-31) — +Total Revenue: 347179000.00
CRNT balance_sheet (annual, 2023-12-31) — Accounts Payable: 67032000.00
CRNT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 104321000.00
CRNT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -131572000.00
CRNT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 437161000.00
CRNT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -24602000.00
CRNT cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 632000.00
CRNT cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 632000.00
CRNT income_statement (annual, 2023-12-31) — Basic Average Shares: 84617774.00
CRNT income_statement (annual, 2023-12-31) — Basic EPS: 0.07
CRNT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 22948000.00
CRNT cash_flow (annual, 2023-12-31) — Capital Expenditure: -12899000.00
CRNT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2944000.00
CRNT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 17605000.00
CRNT balance_sheet (annual, 2023-12-31) — Capital Stock: 224000.00
CRNT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 28237000.00
CRNT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 28237000.00
CRNT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -4861000.00
CRNT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -20870000.00
CRNT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 30887000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Account Payable: -1847000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Inventory: 6303000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 20775000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -4034000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -9829000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Payable: -170000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -170000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Receivables: -2370000.00
CRNT cash_flow (annual, 2023-12-31) — Change In Working Capital: 10675000.00
CRNT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2370000.00
CRNT cash_flow (annual, 2023-12-31) — Changes In Cash: 5156000.00
CRNT balance_sheet (annual, 2023-12-31) — Common Stock: 224000.00
CRNT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 134019000.00
CRNT income_statement (annual, 2023-12-31) — Cost Of Revenue: 227310000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 16570000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Assets: 217940000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3889000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Debt: 32600000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 36489000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 5158000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 8789000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 8789000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Liabilities: 132953000.00
CRNT balance_sheet (annual, 2023-12-31) — Current Provisions: 1694000.00
CRNT balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 4985000.00
CRNT cash_flow (annual, 2023-12-31) — Depreciation: 9335000.00
CRNT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 9967000.00
CRNT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 9967000.00
CRNT income_statement (annual, 2023-12-31) — Diluted Average Shares: 85482626.00
CRNT income_statement (annual, 2023-12-31) — Diluted EPS: 0.07
CRNT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 6220000.00
CRNT income_statement (annual, 2023-12-31) — EBIT: 20280000.00
CRNT income_statement (annual, 2023-12-31) — EBITDA: 30247000.00
CRNT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 133000.00
CRNT balance_sheet (annual, 2023-12-31) — Employee Benefits: 9399000.00
CRNT cash_flow (annual, 2023-12-31) — End Cash Position: 28237000.00
CRNT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4861000.00
CRNT balance_sheet (annual, 2023-12-31) — Finished Goods: 34535000.00
CRNT cash_flow (annual, 2023-12-31) — Free Cash Flow: 17988000.00
CRNT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 61000.00
CRNT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -753000.00
CRNT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -8087000.00
CRNT income_statement (annual, 2023-12-31) — General And Administrative Expense: 23793000.00
CRNT balance_sheet (annual, 2023-12-31) — Goodwill: 7749000.00
CRNT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 24150000.00
CRNT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 128923000.00
CRNT balance_sheet (annual, 2023-12-31) — Gross PPE: 181068000.00
CRNT income_statement (annual, 2023-12-31) — Gross Profit: 119869000.00
CRNT balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 920000.00
CRNT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2839000.00
CRNT income_statement (annual, 2023-12-31) — Interest Expense: 7538000.00
CRNT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 7538000.00
CRNT income_statement (annual, 2023-12-31) — Interest Income: 93000.00
CRNT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 93000.00
CRNT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 6040000.00
CRNT balance_sheet (annual, 2023-12-31) — Inventory: 68811000.00
CRNT balance_sheet (annual, 2023-12-31) — Invested Capital: 166619000.00
CRNT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -20870000.00
CRNT balance_sheet (annual, 2023-12-31) — Leases: 1949000.00
CRNT balance_sheet (annual, 2023-12-31) — Line Of Credit: 32600000.00
CRNT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 13716000.00
CRNT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 13716000.00
CRNT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 160282000.00
CRNT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -7971000.00
CRNT balance_sheet (annual, 2023-12-31) — Net Debt: 4363000.00
CRNT income_statement (annual, 2023-12-31) — Net Income: 6220000.00
CRNT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 6220000.00
CRNT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 6220000.00
CRNT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 6220000.00
CRNT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 6220000.00
CRNT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 6220000.00
CRNT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 6220000.00
CRNT cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -2944000.00
CRNT income_statement (annual, 2023-12-31) — Net Interest Income: -7605000.00
CRNT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -4900000.00
CRNT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -7605000.00
CRNT balance_sheet (annual, 2023-12-31) — Net PPE: 49496000.00
CRNT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -9955000.00
CRNT cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -4900000.00
CRNT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 109869000.00
CRNT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 670000.00
CRNT balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 670000.00
CRNT balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 9399000.00
CRNT income_statement (annual, 2023-12-31) — Normalized EBITDA: 33125000.00
CRNT income_statement (annual, 2023-12-31) — Normalized Income: 8234600.00
CRNT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 30887000.00
CRNT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 61000.00
CRNT income_statement (annual, 2023-12-31) — Operating Income: 23225000.00
CRNT income_statement (annual, 2023-12-31) — Operating Revenue: 347179000.00
CRNT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 85418321.00
CRNT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -8087000.00
CRNT income_statement (annual, 2023-12-31) — Other Gand A: 23793000.00
CRNT income_statement (annual, 2023-12-31) — Other Income Expense: -2878000.00
CRNT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 16401000.00
CRNT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1954000.00
CRNT balance_sheet (annual, 2023-12-31) — Other Payable: 2379000.00
CRNT balance_sheet (annual, 2023-12-31) — Other Properties: 18837000.00
CRNT balance_sheet (annual, 2023-12-31) — Other Receivables: 9530000.00
CRNT balance_sheet (annual, 2023-12-31) — Payables: 69411000.00
CRNT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 85981000.00
CRNT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 963000.00
CRNT income_statement (annual, 2023-12-31) — Pretax Income: 12742000.00
CRNT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 39000.00
CRNT balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRNT cash_flow (annual, 2023-12-31) — Purchase Of Business: -7971000.00
CRNT cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -2944000.00
CRNT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -9955000.00
CRNT balance_sheet (annual, 2023-12-31) — Raw Materials: 33790000.00
CRNT balance_sheet (annual, 2023-12-31) — Receivables: 113851000.00
CRNT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 227310000.00
CRNT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 9967000.00
CRNT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -4900000.00
CRNT income_statement (annual, 2023-12-31) — Research And Development: 32274000.00
CRNT income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 2125000.00
CRNT balance_sheet (annual, 2023-12-31) — Retained Earnings: -275188000.00
CRNT cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CRNT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 40577000.00
CRNT income_statement (annual, 2023-12-31) — Selling General And Administration: 64370000.00
CRNT balance_sheet (annual, 2023-12-31) — Share Issued: 88899844.00
CRNT cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -4900000.00
CRNT income_statement (annual, 2023-12-31) — Special Income Charges: -2125000.00
CRNT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3964000.00
CRNT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 134019000.00
CRNT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 109869000.00
CRNT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -863400.00
CRNT income_statement (annual, 2023-12-31) — Tax Provision: 6522000.00
CRNT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.30
CRNT balance_sheet (annual, 2023-12-31) — Total Assets: 298525000.00
CRNT balance_sheet (annual, 2023-12-31) — Total Capitalization: 134019000.00
CRNT balance_sheet (annual, 2023-12-31) — Total Debt: 50205000.00
CRNT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 134019000.00
CRNT income_statement (annual, 2023-12-31) — Total Expenses: 323954000.00
CRNT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 164506000.00
CRNT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 80585000.00
CRNT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 31553000.00
CRNT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 21210000.00
CRNT income_statement (annual, 2023-12-31) — Total Other Finance Cost: 160000.00
CRNT income_statement (annual, 2023-12-31) — Total Unusual Items: -2878000.00
CRNT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2878000.00
CRNT balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 7768000.00
CRNT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (annual, 2023-12-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (annual, 2023-12-31) — Work In Process: 486000.00
CRNT balance_sheet (annual, 2023-12-31) — Working Capital: 84987000.00
CRNT income_statement (quarterly, 2024-09-30) — Interest Expense: 1834000.00
CRNT income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 1834000.00
CRNT cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: -3250000.00
CRNT balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 670000.00
CRNT balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 670000.00
CRNT balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 25200000.00
CRNT income_statement (annual, 2024-12-31) — +Operating Expense: 95048000.00
CRNT income_statement (annual, 2024-12-31) — +Total Revenue: 394190000.00
CRNT balance_sheet (annual, 2024-12-31) — Accounts Payable: 91157000.00
CRNT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 149619000.00
CRNT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -141374000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -141374000.00
CRNT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 447369000.00
CRNT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -13796000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -13796000.00
CRNT cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 1776000.00
CRNT cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 1776000.00
CRNT income_statement (annual, 2024-12-31) — Basic Average Shares: 86191178.00
CRNT income_statement (annual, 2024-12-31) — Basic EPS: 0.28
CRNT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 28237000.00
CRNT cash_flow (annual, 2024-12-31) — Capital Expenditure: -16464000.00
CRNT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -1883000.00
CRNT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 15907000.00
CRNT balance_sheet (annual, 2024-12-31) — Capital Stock: 232000.00
CRNT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 35311000.00
CRNT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 35311000.00
CRNT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1522000.00
CRNT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -16464000.00
CRNT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 26198000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Account Payable: 23032000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Inventory: 7606000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 5976000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -4196000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -4574000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Payable: 26930000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 26930000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Receivables: -46224000.00
CRNT cash_flow (annual, 2024-12-31) — Change In Working Capital: -14482000.00
CRNT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -46224000.00
CRNT cash_flow (annual, 2024-12-31) — Changes In Cash: 8212000.00
CRNT balance_sheet (annual, 2024-12-31) — Common Stock: 232000.00
CRNT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 166325000.00
CRNT income_statement (annual, 2024-12-31) — Cost Of Revenue: 257339000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 18598000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 18598000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Assets: 261038000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 2971000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Debt: 25200000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 28171000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 4624000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 4624000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 4308000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 4308000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Liabilities: 151448000.00
CRNT balance_sheet (annual, 2024-12-31) — Current Provisions: 2325000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Current Provisions: 2325000.00
CRNT balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 4915000.00
CRNT cash_flow (annual, 2024-12-31) — Depreciation: 10336000.00
CRNT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 12112000.00
CRNT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 12112000.00
CRNT income_statement (annual, 2024-12-31) — Diluted Average Shares: 88460001.00
CRNT income_statement (annual, 2024-12-31) — Diluted EPS: 0.27
CRNT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 24063000.00
CRNT income_statement (annual, 2024-12-31) — EBIT: 33227000.00
CRNT income_statement (annual, 2024-12-31) — EBITDA: 45339000.00
CRNT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1138000.00
CRNT balance_sheet (annual, 2024-12-31) — Employee Benefits: 8359000.00
CRNT cash_flow (annual, 2024-12-31) — End Cash Position: 35311000.00
CRNT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1522000.00
CRNT balance_sheet (annual, 2024-12-31) — Finished Goods: 30447000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Finished Goods: 30447000.00
CRNT cash_flow (annual, 2024-12-31) — Free Cash Flow: 9734000.00
CRNT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 207000.00
CRNT income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -3516000.00
CRNT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -10060000.00
CRNT income_statement (annual, 2024-12-31) — General And Administrative Expense: 14220000.00
CRNT balance_sheet (annual, 2024-12-31) — Goodwill: 7749000.00
CRNT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 24540000.00
CRNT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 163415000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 163415000.00
CRNT balance_sheet (annual, 2024-12-31) — Gross PPE: 194840000.00
CRNT income_statement (annual, 2024-12-31) — Gross Profit: 136851000.00
CRNT balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 508000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 508000.00
CRNT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1127000.00
CRNT income_statement (annual, 2024-12-31) — Interest Expense: 5974000.00
CRNT income_statement (quarterly, 2024-12-31) — Interest Expense: -637000.00
CRNT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 5974000.00
CRNT income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: -637000.00
CRNT income_statement (annual, 2024-12-31) — Interest Income: 143000.00
CRNT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 143000.00
CRNT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 4682000.00
CRNT balance_sheet (annual, 2024-12-31) — Inventory: 59693000.00
CRNT balance_sheet (annual, 2024-12-31) — Invested Capital: 191525000.00
CRNT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -16464000.00
CRNT balance_sheet (annual, 2024-12-31) — Leases: 2582000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Leases: 2582000.00
CRNT balance_sheet (annual, 2024-12-31) — Line Of Credit: 25200000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 25200000.00
CRNT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 12936000.00
CRNT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 12936000.00
CRNT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 175556000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 175556000.00
CRNT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CRNT income_statement (annual, 2024-12-31) — Net Income: 24063000.00
CRNT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 24063000.00
CRNT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 24063000.00
CRNT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 24063000.00
CRNT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 24063000.00
CRNT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 24063000.00
CRNT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 24063000.00
CRNT income_statement (annual, 2024-12-31) — Net Interest Income: -6255000.00
CRNT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -7400000.00
CRNT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6255000.00
CRNT balance_sheet (annual, 2024-12-31) — Net PPE: 53466000.00
CRNT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -14581000.00
CRNT cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -7400000.00
CRNT cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CRNT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 141785000.00
CRNT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
CRNT balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
CRNT balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 0.00
CRNT balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 0.00
CRNT balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 8359000.00
CRNT income_statement (annual, 2024-12-31) — Normalized EBITDA: 53634000.00
CRNT income_statement (annual, 2024-12-31) — Normalized Income: 31387059.19
CRNT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 26198000.00
CRNT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 207000.00
CRNT income_statement (annual, 2024-12-31) — Operating Income: 41803000.00
CRNT income_statement (annual, 2024-12-31) — Operating Revenue: 394190000.00
CRNT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 88392925.00
CRNT balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 3430000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 3430000.00
CRNT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -10060000.00
CRNT income_statement (annual, 2024-12-31) — Other Gand A: 14220000.00
CRNT income_statement (annual, 2024-12-31) — Other Income Expense: -8295000.00
CRNT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 16791000.00
CRNT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1037000.00
CRNT income_statement (annual, 2024-12-31) — Other Operating Expenses: 1160000.00
CRNT balance_sheet (annual, 2024-12-31) — Other Payable: 3459000.00
CRNT balance_sheet (annual, 2024-12-31) — Other Properties: 16702000.00
CRNT balance_sheet (annual, 2024-12-31) — Other Receivables: 9657000.00
CRNT balance_sheet (annual, 2024-12-31) — Payables: 94616000.00
CRNT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 113214000.00
CRNT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1626000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1626000.00
CRNT income_statement (annual, 2024-12-31) — Pretax Income: 27253000.00
CRNT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 5878000.00
CRNT balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRNT balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CRNT cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CRNT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -14581000.00
CRNT balance_sheet (annual, 2024-12-31) — Raw Materials: 28549000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Raw Materials: 28549000.00
CRNT balance_sheet (annual, 2024-12-31) — Receivables: 159276000.00
CRNT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 257339000.00
CRNT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 12112000.00
CRNT cash_flow (annual, 2024-12-31) — Repayment Of Debt: -7400000.00
CRNT income_statement (annual, 2024-12-31) — Research And Development: 34951000.00
CRNT income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 4779000.00
CRNT balance_sheet (annual, 2024-12-31) — Retained Earnings: -251125000.00
CRNT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 44717000.00
CRNT income_statement (annual, 2024-12-31) — Selling General And Administration: 58937000.00
CRNT balance_sheet (annual, 2024-12-31) — Share Issued: 91874448.00
CRNT cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -7400000.00
CRNT income_statement (annual, 2024-12-31) — Special Income Charges: -4779000.00
CRNT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4298000.00
CRNT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 166325000.00
CRNT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 141785000.00
CRNT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -970940.81
CRNT income_statement (annual, 2024-12-31) — Tax Provision: 3190000.00
CRNT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.12
CRNT balance_sheet (annual, 2024-12-31) — Total Assets: 344996000.00
CRNT balance_sheet (annual, 2024-12-31) — Total Capitalization: 166325000.00
CRNT balance_sheet (annual, 2024-12-31) — Total Debt: 41107000.00
CRNT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 166325000.00
CRNT income_statement (annual, 2024-12-31) — Total Expenses: 352387000.00
CRNT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 178671000.00
CRNT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 83958000.00
CRNT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 27223000.00
CRNT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 38727000.00
CRNT income_statement (annual, 2024-12-31) — Total Other Finance Cost: 424000.00
CRNT income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -6187000.00
CRNT income_statement (annual, 2024-12-31) — Total Unusual Items: -8295000.00
CRNT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -8295000.00
CRNT balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 5928000.00
CRNT balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (annual, 2024-12-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (annual, 2024-12-31) — Work In Process: 697000.00
CRNT balance_sheet (quarterly, 2024-12-31) — Work In Process: 697000.00
CRNT balance_sheet (annual, 2024-12-31) — Working Capital: 109590000.00
CRNT income_statement (quarterly, 2025-03-31) — +Operating Expense: 25982000.00
CRNT income_statement (quarterly, 2025-03-31) — +Total Revenue: 88652000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 88576000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 145740000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 449516000.00
CRNT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 88742804.00
CRNT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
CRNT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 35311000.00
CRNT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4007000.00
CRNT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -538000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 15571000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 232000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 27688000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 27688000.00
CRNT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 508000.00
CRNT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -10577000.00
CRNT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 2610000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4084000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Inventory: -2079000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -409000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -825000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -143000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Payable: -3330000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3330000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 6384000.00
CRNT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -402000.00
CRNT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 6384000.00
CRNT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -7459000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Common Stock: 232000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 167007000.00
CRNT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 59553000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Assets: 253649000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3130000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Debt: 25200000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 28330000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2400000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2400000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 150486000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 4613000.00
CRNT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3332000.00
CRNT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3332000.00
CRNT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 88742804.00
CRNT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
CRNT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — EBIT: 3117000.00
CRNT income_statement (quarterly, 2025-03-31) — EBITDA: 6449000.00
CRNT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -164000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 8104000.00
CRNT cash_flow (quarterly, 2025-03-31) — End Cash Position: 27688000.00
CRNT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 508000.00
CRNT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1397000.00
CRNT cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 10000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -10545000.00
CRNT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5436000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Goodwill: 11046000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 33339000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 53724000.00
CRNT income_statement (quarterly, 2025-03-31) — Gross Profit: 29099000.00
CRNT income_statement (quarterly, 2025-03-31) — Interest Income: 990000.00
CRNT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 990000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Inventory: 62343000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 192207000.00
CRNT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -10577000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 12441000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 12441000.00
CRNT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
CRNT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -6570000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Income: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -980000.00
CRNT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -980000.00
CRNT income_statement (quarterly, 2025-03-31) — Net Interest Income: 990000.00
CRNT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CRNT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CRNT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 990000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Net PPE: 53724000.00
CRNT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3469000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 133668000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 8104000.00
CRNT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 10656000.00
CRNT income_statement (quarterly, 2025-03-31) — Normalized Income: 1964900.00
CRNT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2610000.00
CRNT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 10000.00
CRNT income_statement (quarterly, 2025-03-31) — Operating Income: 3117000.00
CRNT income_statement (quarterly, 2025-03-31) — Operating Revenue: 88652000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 88929716.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 25200000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -10545000.00
CRNT income_statement (quarterly, 2025-03-31) — Other Gand A: 5436000.00
CRNT income_statement (quarterly, 2025-03-31) — Other Income Expense: -4207000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 22293000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 854000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Payable: 31180000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Properties: 53724000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Other Receivables: 17878000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Payables: 119756000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 119756000.00
CRNT income_statement (quarterly, 2025-03-31) — Pretax Income: -100000.00
CRNT cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 508000.00
CRNT cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -6570000.00
CRNT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3469000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Receivables: 163618000.00
CRNT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 59553000.00
CRNT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3332000.00
CRNT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
CRNT income_statement (quarterly, 2025-03-31) — Research And Development: 8249000.00
CRNT income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 4207000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -252105000.00
CRNT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 12297000.00
CRNT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 17733000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Share Issued: 92411239.00
CRNT income_statement (quarterly, 2025-03-31) — Special Income Charges: -4207000.00
CRNT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 650000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 167007000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 133668000.00
CRNT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -1262100.00
CRNT income_statement (quarterly, 2025-03-31) — Tax Provision: 880000.00
CRNT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
CRNT balance_sheet (quarterly, 2025-03-31) — Total Assets: 346179000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 167007000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Total Debt: 40771000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 167007000.00
CRNT income_statement (quarterly, 2025-03-31) — Total Expenses: 85535000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 179172000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 92530000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 28686000.00
CRNT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1090000.00
CRNT income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -990000.00
CRNT income_statement (quarterly, 2025-03-31) — Total Unusual Items: -4207000.00
CRNT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4207000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 8141000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (quarterly, 2025-03-31) — Working Capital: 103163000.00
CRNT income_statement (quarterly, 2025-06-30) — +Operating Expense: 25994000.00
CRNT income_statement (quarterly, 2025-06-30) — +Total Revenue: 82262000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 73759000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 124051000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 452709000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -13942000.00
CRNT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 89470719.00
CRNT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.01
CRNT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 27688000.00
CRNT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5130000.00
CRNT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1173000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 17051000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 234000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 29216000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 29216000.00
CRNT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -4557000.00
CRNT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -5130000.00
CRNT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 10762000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -13961000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Inventory: 2206000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 144000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -90000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 56000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Payable: -17246000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -17246000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Receivables: 21778000.00
CRNT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 6848000.00
CRNT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 21778000.00
CRNT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1075000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Common Stock: 234000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 171777000.00
CRNT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 53822000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Assets: 234205000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3727000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Debt: 20500000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 24227000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2426000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2426000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 125865000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 5140000.00
CRNT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3632000.00
CRNT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3632000.00
CRNT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 89470719.00
CRNT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.01
CRNT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1267000.00
CRNT income_statement (quarterly, 2025-06-30) — EBIT: 2446000.00
CRNT income_statement (quarterly, 2025-06-30) — EBITDA: 6078000.00
CRNT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 453000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 8661000.00
CRNT cash_flow (quarterly, 2025-06-30) — End Cash Position: 29216000.00
CRNT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -4557000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Finished Goods: 33171000.00
CRNT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 5632000.00
CRNT cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
CRNT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -7703000.00
CRNT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 6940000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Goodwill: 11046000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 33467000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 137993000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 54714000.00
CRNT income_statement (quarterly, 2025-06-30) — Gross Profit: 28440000.00
CRNT income_statement (quarterly, 2025-06-30) — Interest Expense: 2896000.00
CRNT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2896000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Inventory: 59944000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 192277000.00
CRNT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -5130000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 13324000.00
CRNT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 13324000.00
CRNT cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CRNT income_statement (quarterly, 2025-06-30) — Net Income: -1267000.00
CRNT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1267000.00
CRNT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1267000.00